181 related articles for article (PubMed ID: 19395448)
1. Lupus and cancer.
Gayed M; Bernatsky S; Ramsey-Goldman R; Clarke A; Gordon C
Lupus; 2009 May; 18(6):479-85. PubMed ID: 19395448
[TBL] [Abstract][Full Text] [Related]
2. Systemic lupus and malignancies.
Bernatsky S; Kale M; Ramsey-Goldman R; Gordon C; Clarke AE
Curr Opin Rheumatol; 2012 Mar; 24(2):177-81. PubMed ID: 22227880
[TBL] [Abstract][Full Text] [Related]
3. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
4. Systemic lupus erythematosus and malignancies: a review article.
Tessier-Cloutier B; Clarke AE; Ramsey-Goldman R; Gordon C; Hansen JE; Bernatsky S
Rheum Dis Clin North Am; 2014 Aug; 40(3):497-506, viii. PubMed ID: 25034158
[TBL] [Abstract][Full Text] [Related]
5. Malignancy and systemic lupus erythematosus.
Bernatsky S; Clarke A; Ramsey-Goldman R
Curr Rheumatol Rep; 2002 Aug; 4(4):351-8. PubMed ID: 12126588
[TBL] [Abstract][Full Text] [Related]
6. Malignancy in systemic lupus erythematosus: what have we learned?
Bernatsky S; Ramsey-Goldman R; Clarke AE
Best Pract Res Clin Rheumatol; 2009 Aug; 23(4):539-47. PubMed ID: 19591783
[TBL] [Abstract][Full Text] [Related]
7. Risk of malignancy in patients with systemic lupus erythematosus: Systematic review and meta-analysis.
Clarke AE; Pooley N; Marjenberg Z; Langham J; Nicholson L; Langham S; Embleton N; Wang X; Desta B; Barut V; Hammond ER
Semin Arthritis Rheum; 2021 Dec; 51(6):1230-1241. PubMed ID: 34710720
[TBL] [Abstract][Full Text] [Related]
8. The Cancer Risk Profile of Systemic Lupus Erythematosus Patients.
Hardenbergh D; Naik R; Manno R; Azar A; Monroy Trujillo JM; Adler B; Haque U; Timlin H
J Clin Rheumatol; 2022 Jan; 28(1):e257-e262. PubMed ID: 33657590
[TBL] [Abstract][Full Text] [Related]
9. Exploring the links between systemic lupus erythematosus and cancer.
Bernatsky S; Ramsey-Goldman R; Clarke A
Rheum Dis Clin North Am; 2005 May; 31(2):387-402, viii-ix. PubMed ID: 15922152
[TBL] [Abstract][Full Text] [Related]
10. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
11. Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival.
Kariniemi S; Rantalaiho V; Virta LJ; Kautiainen H; Puolakka K; Elfving P
Lupus; 2022 Dec; 31(14):1750-1758. PubMed ID: 36200539
[TBL] [Abstract][Full Text] [Related]
12. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of factors influencing cancer risk in women with lupus: social habits, reproductive issues, and obesity.
Bernatsky S; Boivin JF; Joseph L; St Pierre Y; Moore A; Rajan R; Clarke A
J Rheumatol; 2002 Dec; 29(12):2551-4. PubMed ID: 12465150
[TBL] [Abstract][Full Text] [Related]
14. Malignancies in systemic lupus erythematosus.
Kiss E; Kovacs L; Szodoray P
Autoimmun Rev; 2010 Feb; 9(4):195-9. PubMed ID: 19643208
[TBL] [Abstract][Full Text] [Related]
15. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
16. Systemic lupus erythematosus and lymphoma: Incidence, pathogenesis and biology.
Klein A; Polliack A; Gafter-Gvili A
Leuk Res; 2018 Dec; 75():45-49. PubMed ID: 30458319
[TBL] [Abstract][Full Text] [Related]
17. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the issue of malignancy risk in systemic lupus erythematosus.
Bernatsky S; Ramsey-Goldman R; Clarke AE
Curr Rheumatol Rep; 2005 Dec; 7(6):476-81. PubMed ID: 16303109
[TBL] [Abstract][Full Text] [Related]
19. Managing cancer risk in patients with systemic lupus erythematous.
Ladouceur A; Bernatsky S; Ramsey-Goldman R; Clarke AE
Expert Rev Clin Immunol; 2018 Oct; 14(10):793-802. PubMed ID: 30183456
[TBL] [Abstract][Full Text] [Related]
20. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
